Latest Posts
- Pharma
- March 28, 2026
Diabetic drug metformin found to act on brain
NEW DELHI: Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…
- Pharma
- March 28, 2026
Hetero debuts semaglutide generic in emerging markets
New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…
- Pharma
- March 27, 2026
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Phase 2 results for LB-102 showed statistically significant reductions in PANSS total score across all doses with onset by week 1 and sustained through study end, alongside low rates of…
- Pharma
- March 27, 2026
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
After substandard drug manufacturing, the state drug firms are once again under the scanner of the central government for manufacture and sale of unapproved fixed dose combination (FDC) drugs which…
- Pharma
- March 27, 2026
Stem cell therapy for autism illegal: NMC advisory
New Delhi: The National Medical Commission (NMC) issued a strict advisory on March 25, 2026, declaring stem cell therapy illegal for treating Autism Spectrum Disorder and cerebral palsy in routine…
- Pharma
- March 26, 2026
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Prices of nearly 900 essential medicines, including painkillers and antibiotics, are set to rise by around 0.65 per cent starting 1 April following a directive from India’s drug pricing regulator.…
- Pharma
- March 26, 2026
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
The court also asked Dr Reddy’s to inform it by Friday whether it is willing to drop the “Olymviq” brand name, as the matter centres around alleged trademark similarity with…
- Pharma
- March 26, 2026
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
New Delhi: The National Pharmaceutical Pricing Authority (NPPA) on Wednesday announced that manufacturers may increase prices of scheduled formulations included in the National List of Essential Medicines (NLEM) by 0.64…
- Uncategorized
- March 25, 2026
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha
New Delhi: The Ministry of AYUSH has detailed its regulatory framework and ongoing initiatives to monitor heavy metal content in traditional medicines, responding to parliamentary concerns over quality and safety…
- Pharma
- March 25, 2026
Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS
New Delhi: The Union Government has clarified that the regulation, licensing, and oversight of hair transplant and cosmetic surgery clinics remain primarily the responsibility of State Governments and Union Territories,…
- Pharma
- March 24, 2026
24-year-old woman dies during surgery; Five UP doctors booked for negligence
Ballia: In an alleged case of medical negligence, a case has been registered against five doctors at a private hospital in Ballia, Uttar Pradesh, following the death of a 24-year-old…
- Pharma
- March 24, 2026
Extortion, Fake Medicines: The Fall Of Surat’s Yoga Guru
The yoga guru, who was arrested last week, misled people in the name of faith and Ayurveda, said investigators. Surat: Just days after Ahmedabad cops dismantled a massive fake currency…
- Pharma
- March 24, 2026
Taisho-controlled pharma giant DHG posts 9.4% net profit surge in 2025
DHG Pharmaceutical JSC (HoSE: DHG), one of the leading pharmaceutical firms in Vietnam, reported audited net profit of VND852 billion ($32.35 million) in 2025, down 5% from its pre-audit figure,…
- Hospitals
- March 24, 2026
Ship of Domestic Medical Device Industry flounders, thanks to Israel-Iran War
Association of Indian Medical Device Industry (AiMeD) sends SOS to Union Minister Piyush Goel New Delhi: The war tremors have started shaking the domestic medical device industry perched on the…
- Pharma
- March 23, 2026
DCGI Cracks Down On 90 Unapproved Fixed-Dose Combinations: Cough Syrups, Vitamins, Diabetes Drugs Among Those Flagged For Sale Without Central Approval
New Delhi — India’s top drug regulator has issued a nationwide alert over 90 fixed-dose combination (FDC) drugs being manufactured and sold without mandatory central approval, directing all state and…
- Pharma
- March 23, 2026
India’s drug body flags 90 unapproved FDC medicines, states told to take action
The Central Drugs Standard Control Organisation (CDSCO), India’s top drug regulator, has identified at least 90 unapproved fixed-dose combination (FDC) medicines in circulation and asked states to move against those…
- Pharma
- March 23, 2026
India advancing as a global hub of affordable, quality healthcare solutions: Dr Jitendra Singh
New Delhi: Union Minister Dr Jitendra Singh on Saturday said that India is steadily evolving into a robust pharma economy, which could help as a significant contributor to the country’s…
- Pharma
- March 21, 2026
Unapproved drops for dry eyes pose risks: Govt
NEW DELHI: Flagging that certain yet-to-be-approved dry eye relief drops are being sold in the market, the central drugs regulator has asked states to cancel any permissions granted for these…
- Pharma
- March 21, 2026
Semaglutide Patent Expires: Will Diabetes, Weight-Loss Treatment Become More Accessible For Patients?
The global conversation around obesity and type 2 diabetes management has shifted dramatically in recent years, largely due to the rise of GLP-1 receptor compounds. Among them, semaglutide has emerged…
- Hospitals
- March 21, 2026
Inaugural Conference of ‘Critical Nephrology Society of India’ (CNSI) puts Best Foot Forward
Dr D S Rana, Chairman, Sir Ganga Ram Trust Society was Cynosure of all Eyes New Delhi: Inaugural Conference of Critical Nephrology Society of India CNSICON 26 under the aegis…

Diabetic drug metformin found to act on brain
Hetero debuts semaglutide generic in emerging markets
LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial
Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority
Stem cell therapy for autism illegal: NMC advisory
India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework
Delhi HC Asks Dr Reddy’s To Halt Olymviq Sales; Flags Similarity With Novo Nordisk’s Ozempic
NPPA allows 0.64% hike in MRP of essential drugs in line with WPI rise
Govt Outlines AYUSH Heavy Metal Monitoring Steps In Rajya Sabha
Regulation Of Hair Transplant And Cosmetic Clinics Under The Purview Of States, No Plans To Create A Central Database Or Registry: Govt In RS








